Health Catalyst, Inc.
Health Catalyst, Inc. (HCAT) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
hcat · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Health Catalyst, Inc. (HCAT) measures how much investors pay for each dollar of the company's trailing earnings. HCAT's current PE ratio of N/A is calculated by dividing its stock price of $1.75 by its TTM earnings per share of -$3.65.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2017 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Medical - Healthcare Information Services · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Health Catalyst, Inc.You HCAT | $129M | N/A | — | -$3.65 |
 Caribou Biosciences, Inc. CRBU | $182M | N/A | — | -$1.59 |
 Enanta Pharmaceuticals, Inc. ENTA | $257M | N/A | — | -$3.84 |
 Solana Company HSDT | $81M | N/A | — | -$1.85 |
 Nano-X Imaging Ltd. NNOX | $127M | N/A | — | -$1.16 |
 Orchestra BioMed Holdings, Inc. OBIO | $237M | N/A | — | -$1.37 |
 Outset Medical, Inc. OM | $80M | N/A | — | -$5.37 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | — | $-2.55 | — | |
2024-12-31 FY2024 | — | $-1.15 | — | |
2023-12-31 FY2023 | — | $-2.09 | — | |
2022-12-31 FY2022 | — | $-2.56 | — | |
2021-12-31 FY2021 | — | $-3.23 | — | |
2020-12-31 FY2020 | — | $-2.91 | — | |
2019-12-31 FY2019 | — | $-3.21 | — | |
2018-12-31 FY2018 | — | $-2.23 | — | |
2017-12-31 FY2017 | — | $-1.69 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Health Catalyst, Inc. (HCAT) measures how much investors pay for each dollar of the company's trailing earnings. HCAT's current PE ratio of N/A is calculated by dividing its stock price of $1.75 by its TTM earnings per share of -$3.65.
Frequently asked questions
HCAT pe ratio · 6 questionsHCAT's current PE ratio is N/A as of 2026-06-08, based on a stock price of $1.75 and TTM EPS of -$3.65. Data sourced from Financial Modeling Prep via HCAT's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Health Catalyst, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08